TY  - GEN
AU  - Jiang,Xiaoyan
AU  - Forrest,Donna
AU  - Nicolini,Franck
AU  - Turhan,Ali
AU  - Guilhot,Joelle
AU  - Yip,Calvin
AU  - Holyoake,Tessa
AU  - Jorgensen,Heather
AU  - Lambie,Karen
AU  - Saw,Kyi Min
AU  - Pang,Emily
AU  - Vukovic,Ranko
AU  - Lehn,Paeta
AU  - Ringrose,Ashley
AU  - Yu,Miao
AU  - Brinkman,Ryan R
AU  - Smith,Clay
AU  - Eaves,Allen
AU  - Eaves,Connie
TI  - Properties of CD34+ CML stem/progenitor cells that correlate with different clinical responses to imatinib mesylate
SN  - 1528-0020
PY  - 2010///1027
KW  - Adult
KW  - Aged
KW  - Antigens, CD34
KW  - Benzamides
KW  - Cells, Cultured
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Humans
KW  - Imatinib Mesylate
KW  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Neoplastic Stem Cells
KW  - drug effects
KW  - Piperazines
KW  - pharmacology
KW  - Prognosis
KW  - Pyrimidines
KW  - Stem Cells
KW  - Young Adult
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1182/blood-2009-05-222471
ER  -